125 related articles for article (PubMed ID: 10644607)
1. Inhibition by calcium antagonism of circulating and renal endothelin in experimental congestive heart failure.
Wei C; Burnett JC
Am J Physiol Heart Circ Physiol; 2000 Jan; 278(1):H263-8. PubMed ID: 10644607
[TBL] [Abstract][Full Text] [Related]
2. Atrial and pulmonary endothelin mRNA is increased in a canine model of chronic low cardiac output.
Wei CM; Clavell AL; Burnett JC
Am J Physiol; 1997 Aug; 273(2 Pt 2):R838-44. PubMed ID: 9277577
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin converting enzyme inhibition modulates endogenous endothelin in chronic canine thoracic inferior vena caval constriction.
Clavell AL; Mattingly MT; Stevens TL; Nir A; Wright S; Aarhus LL; Heublein DM; Burnett JC
J Clin Invest; 1996 Mar; 97(5):1286-92. PubMed ID: 8636441
[TBL] [Abstract][Full Text] [Related]
4. Endothelin in thoracic inferior vena caval constriction model of heart failure.
Underwood RD; Aarhus LL; Heublein DM; Burnett JC
Am J Physiol; 1992 Sep; 263(3 Pt 2):H951-5. PubMed ID: 1415622
[TBL] [Abstract][Full Text] [Related]
5. Enhanced coronary vasoconstriction to endothelin-B-receptor activation in experimental congestive heart failure.
Cannan CR; Burnett JC; Lerman A
Circulation; 1996 Feb; 93(4):646-51. PubMed ID: 8640990
[TBL] [Abstract][Full Text] [Related]
6. Biological actions of brain natriuretic peptide in thoracic inferior vena caval constriction.
Clavell AL; Stingo AJ; Aarhus LL; Burnett JC
Am J Physiol; 1993 Dec; 265(6 Pt 2):R1416-22. PubMed ID: 8285286
[TBL] [Abstract][Full Text] [Related]
7. Chronic oral endothelin type A receptor antagonism in experimental heart failure.
Borgeson DD; Grantham JA; Williamson EE; Luchner A; Redfield MM; Opgenorth TJ; Burnett JC
Hypertension; 1998 Mar; 31(3):766-70. PubMed ID: 9495259
[TBL] [Abstract][Full Text] [Related]
8. Restoration of renal response to atrial natriuretic factor in experimental low-output heart failure.
Redfield MM; Edwards BS; Heublein DM; Burnett JC
Am J Physiol; 1989 Oct; 257(4 Pt 2):R917-23. PubMed ID: 2529785
[TBL] [Abstract][Full Text] [Related]
9. Increased endothelin in experimental heart failure.
Margulies KB; Hildebrand FL; Lerman A; Perrella MA; Burnett JC
Circulation; 1990 Dec; 82(6):2226-30. PubMed ID: 2242543
[TBL] [Abstract][Full Text] [Related]
10. Role of endogenous atrial natriuretic factor in acute congestive heart failure.
Lee ME; Miller WL; Edwards BS; Burnett JC
J Clin Invest; 1989 Dec; 84(6):1962-6. PubMed ID: 2531762
[TBL] [Abstract][Full Text] [Related]
11. Endothelin stimulates an endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine, in experimental heart failure.
Ohnishi M; Wada A; Tsutamoto T; Fujii M; Matsumoto T; Yamamoto T; Takayama T; Wang X; Kinoshita M
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():241S-244S. PubMed ID: 12193095
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of ET(A) and ET(B) in the renal tissue of rats with compensated and decompensated heart failure.
Francis BN; Abassi Z; Heyman S; Winaver J; Hoffman A
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S362-5. PubMed ID: 15838321
[TBL] [Abstract][Full Text] [Related]
13. Activation of cardiorenal and pulmonary tissue endothelin-1 in experimental heart failure.
Luchner A; Jougasaki M; Friedrich E; Borgeson DD; Stevens TL; Redfield MM; Riegger GA; Burnett JC
Am J Physiol Regul Integr Comp Physiol; 2000 Sep; 279(3):R974-9. PubMed ID: 10956256
[TBL] [Abstract][Full Text] [Related]
14. [Recombinant human brain natriuretic peptide on the cardiac hemodynamics and renal function in dogs with heart failure].
Xu XW; Zeng GY; Yang Y; Liu HX
Yao Xue Xue Bao; 2002 Oct; 37(10):758-62. PubMed ID: 12567856
[TBL] [Abstract][Full Text] [Related]
15. Effects of a specific endothelin-converting enzyme inhibitor on cardiac, renal, and neurohumoral functions in congestive heart failure: comparison of effects with those of endothelin A receptor antagonism.
Wada A; Tsutamoto T; Ohnishi M; Sawaki M; Fukai D; Maeda Y; Kinoshita M
Circulation; 1999 Feb; 99(4):570-7. PubMed ID: 9927406
[TBL] [Abstract][Full Text] [Related]
16. Chronic administration of phosphodiesterase type 5 inhibitor suppresses renal production of endothelin-1 in dogs with congestive heart failure.
Yamamoto T; Wada A; Ohnishi M; Tsutamoto T; Fujii M; Matsumoto T; Takayama T; Wang X; Kurokawa K; Kinoshita M
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():258S-262S. PubMed ID: 12193099
[TBL] [Abstract][Full Text] [Related]
17. Endothelin in experimental congestive heart failure in the anesthetized dog.
Cavero PG; Miller WL; Heublein DM; Margulies KB; Burnett JC
Am J Physiol; 1990 Aug; 259(2 Pt 2):F312-7. PubMed ID: 2201206
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular actions of ET-B activation in vivo and modulation by receptor antagonism.
Rasmussen TE; Jougasaki M; Supaporn T; Hallett JW; Brooks DP; Burnett JC
Am J Physiol; 1998 Jan; 274(1):R131-8. PubMed ID: 9458909
[TBL] [Abstract][Full Text] [Related]
19. Endothelin A receptor antagonism in experimental congestive heart failure results in augmentation of the renin-angiotensin system and sustained sodium retention.
Schirger JA; Chen HH; Jougasaki M; Lisy O; Boerrigter G; Cataliotti A; Burnett JC
Circulation; 2004 Jan; 109(2):249-54. PubMed ID: 14691038
[TBL] [Abstract][Full Text] [Related]
20. Effects of calcium antagonist felodipine on renal sympathetic nerve activity in rats with congestive heart failure.
Zhang W; Sun X; Zhao X; Thorén P; Hedner T
Cardiovasc Drugs Ther; 1997 Nov; 11(5):645-50. PubMed ID: 9493702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
